Investigators trained and validated a deep-learning AI model to identify patients with high-risk NMIBC unlikely to benefit from BCG. Artificial intelligence (AI)-based histologic assays identify ...
ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference ...
Jane Akinyi (right) holding her baby while a medic adminster a Bacillus Calmette–Guérin vaccine(BCG) vaccine at Forest Dispensary in Nakuru on January 28,2019.Most of the hospitals in the county are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results